News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Medical Developments International.
RELATED STOCKHEAD STORIES
Health & Biotech
Air pollution is expected to get worse, but these small caps are trying to help and they just might benefit
Health & Biotech
Health: NZ restricts codeine, painkiller stocks celebrate
Health & Biotech
Health: China loves Aussie food, maybe next it’ll love MVP’s Green Whistle too
Health & Biotech
Health: Botanix shares fall 50% after failed clinical trial
Health & Biotech
These Aussie small caps are trying to tackle the opioid crisis
Health & Biotech
Dr Boreham’s Crucible: PharmAust wants a piece of the +$US10.2b pet drug market
Health & Biotech
Fliers, flameouts and fakers: what happened in biotechland in 2018
News
Austrade is picking tech as the next China winner, but small caps are still backing consumer products
Health & Biotech
Green whistle maker Med Dev is living the China dream with a new $46m deal
Director Trades
Director Trades: Who’s in the money and who’s buying up large?
Health & Biotech
Tax cut takes a bite out of Penthrox maker Medical Development’s profits
Health & Biotech
US roadblocks hurt Aussie green whistle maker Medical Developments
Director Trades
Director Trades: Who’s buying and selling their own stock?
Health & Biotech
Four key factors impacting health and med-tech stocks in 2018
Director Trades
Director Trades: Which small cap insiders are buying and which are selling?
Health & Biotech
Green whistle maker Medical Dev drops 17pc after revenue warning
Health & Biotech